• News
  • Stock Screener
  • Small Caps
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Review
  • X (Twitter)
  • LinkedIn
#

: 1
US regulators have denied Modernas application for approval of a new flu vaccine / Photo: Shutterstock.com/Golden Shrimp
News·12.02.2026 02:46
Moderna's stock fell due to regulatory concerns. A more important development is also under attack
  • MRNA
X-channel

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2025